Oliver Jr. Amends Filing for Rise Gold Corp.

Ticker: RYES · Form: SC 13D/A · Filed: Apr 12, 2024 · CIK: 1424864

Rise Gold Corp. SC 13D/A Filing Summary
FieldDetail
CompanyRise Gold Corp. (RYES)
Form TypeSC 13D/A
Filed DateApr 12, 2024
Risk Levelmedium
Pages10
Reading Time12 min
Key Dollar Amounts$0.095, $0.158, $0.60, $1.00, $0.26
Sentimentneutral

Sentiment: neutral

Topics: ownership-change, sec-filing, mining

Related Tickers: ROSE

TL;DR

Oliver Jr. updated his stake in Rise Gold Corp. (ROSE) - watch for potential moves.

AI Summary

Daniel Oliver Jr. has filed an amendment (SC 13D/A) to his Schedule 13D regarding Rise Gold Corp. as of April 12, 2024. This filing indicates a change in beneficial ownership. Oliver Jr. is listed with a mailing address in New Canaan, CT.

Why It Matters

This filing signals a potential shift in control or significant stakeholding in Rise Gold Corp., which could influence the company's future strategic decisions and stock performance.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can indicate activist investor intent or significant shifts in major holdings, requiring closer monitoring.

Key Players & Entities

  • Daniel Oliver Jr. (person) — Filer of the Schedule 13D/A
  • Rise Gold Corp. (company) — Subject company
  • MYRMIKAN CAPITAL, LLC (company) — Group Member
  • MYRMIKAN GOLD FUND, LLC (company) — Group Member

FAQ

What is the specific change in beneficial ownership reported in this SC 13D/A filing?

The filing is an amendment (Amendment No. 2) to a Schedule 13D, indicating a change in beneficial ownership, but the exact details of the change are not specified in the provided header information.

Who is Daniel Oliver Jr. in relation to Rise Gold Corp.?

Daniel Oliver Jr. is the person filing the Schedule 13D/A, indicating he is a significant beneficial owner of Rise Gold Corp. common stock.

When was this filing made and what is the 'date as of change'?

The filing was made on April 12, 2024, and the 'date as of change' is also April 12, 2024.

What is the CUSIP number for Rise Gold Corp. common stock?

The CUSIP number for Rise Gold Corp. common stock is 76760R100.

What are the business and mailing addresses for Rise Gold Corp.?

The business and mailing addresses for Rise Gold Corp. are both listed as Suite 650, 669 Howe Street, Vancouver, A1, V6C 0B4.

Filing Stats: 2,963 words · 12 min read · ~10 pages · Grade level 11.4 · Accepted 2024-04-12 21:25:57

Key Financial Figures

  • $0.095 — rivate offering for a purchase price of $0.095 per Unit (the " Purchase Price "). Each
  • $0.158 — 's common stock at an exercise price of $0.158 for a term of three years. The Fund use
  • $0.60 — e 230217-DW02.02 115,000 2-17-25 US$0.60 190909-W09.03 374,000 9-9-24 C$1.0
  • $1.00 — 0.60 190909-W09.03 374,000 9-9-24 C$1.00 2. This Agreement will terminate and
  • $0.26 — 58 231207-W02.20 140,000 12-7-25 US$0.26 231107-W01.01 750,000 11-7-25 US$0

Filing Documents

Security and Issuer

Item 1. Security and Issuer. The name of the issuer is Rise Gold Corp., a Nevada corporation (the " Issuer "), which has its principal executive offices at Suite 650, 669 Howe Street, Vancouver, British Columbia, Canada V6C 0B4. This report relates to the Issuer's class of common stock without par value.

Identity and Background

Item 2. Identity and Background. (a): This Schedule 13D amendment (this "Amendment") has been jointly filed by Daniel Oliver Jr. as an individual, Myrmikan Gold Fund, LLC, a private investment fund (the " Fund "), and Myrmikan Capital, LLC, an investment adviser and manager of the Fund (the " Manager "). Mr. Oliver owns a 97.5% membership interest in, and is the manager of, the Manager. The parties filing the Schedule 13D are also referred to herein as "reporting persons." (b): The address of each of the reporting persons is 713 Silvermine Road, New Canaan, Connecticut 06840. (c): The Fund's principal business is investing in securities. The Manager's principal business is providing investment management for the Fund. Mr. Oliver's principal business is acting as manager of the Manager and providing investment management for the Fund. (d): During the last five years none of the reporting persons has been convicted in a criminal proceeding. (e): During the last five years, none of the reporting persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in their being subject, either currently or in the past, to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f): Mr. Oliver is citizen of the United States. The Fund is a Delaware limited liability company. The Manager is a Delaware limited liability company.

Source and Amount of Funds or Other Consideration

Item 3. Source and Amount of Funds or Other Consideration. On April 9, 2024, the Fund purchased 2,700,000 units (the " Units ") from the Issuer in a private offering for a purchase price of $0.095 per Unit (the " Purchase Price "). Each Unit was comprised of one share of the Issuer's common stock and one-half common stock purchase warrant (each whole warrant, a " Warrant "). By its terms, each whole Warrant is exercisable to buy an additional share of the Issuer's common stock at an exercise price of $0.158 for a term of three years. The Fund used its own investment funds to pay the Purchase Price. See Items 5, 6 and 7 below for additional information regarding the Warrants and other warrants held by the reporting persons.

Purpose of Transaction

Item 4. Purpose of Transaction. The Fund purchased the Units as described in Item 3 for investment purposes. All securities of the Issuer that are beneficially owned by the reporting persons are held for investment purposes. Mr. Oliver intends to continue to seek to influence the policies of the Issuer with a goal of maximizing the value of the Issuer's common stock. As of the date hereof, and except as otherwise disclosed herein, Mr. Oliver, the Fund and the Manager do not have any plans or proposals which relate to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the management of the Issuer or any change in the present board of directors of the Issuer other than in connection with the normal nominating process of the full board of directors for the Issuer's annual meeting of stockholders; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure; (g) Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions that may impede the acquisition of control of the Issuer by any person; (h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above. The reporting persons may purchase, sell or transfer common stock benefi

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer. (a) - (b) As of the date of this report, Mr. Oliver beneficially owns, directly or indirectly, a total of 10,305,807 shares of the Issuer's common stock, which constitutes 19.9% of the class of common stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934. The Fund beneficially owns a total of 9,872,849 shares of common stock, which constitutes 19.2% of the class as calculated in accordance with Rule 13d-3. As the manager of the Fund, the Manager is deemed to share beneficial ownership of the shares beneficially owned by the Fund. As the manager of the Manager, Mr. Oliver is likewise deemed to share beneficial ownership of the shares beneficially owned by the Fund and the Manager. Rule 13d-3 provides, in part, that shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option or warrant) within 60 days. In computing the percentage ownership of any person under Rule 13d-3, the number of shares outstanding is deemed to include the number of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of the person does not necessarily reflect a person's actual ownership or voting power with respect to the number of shares actually outstanding. All shares of common stock listed in the table below are currently beneficially owned, directly or indirectly, by Mr. Oliver. The Fund and the Manager share beneficial ownership of the 9,872,849 shares of common stock held by the Fund. As of April 9, 2024, a total of 51,486,682 shares of the Issuer's common stock were outstanding. Outstanding Shares Shares Underlying Currently Exercisable Warrants or Options Registered Holders 138,888 (1) Mr. Oliver 294,070 (1) (Underlying Options) Mr. Oliver 9,872,849 ( 2 ) The Fund (1) Voting and dispositive power hel

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. Mr. Oliver serves as a member of the Board of Directors of the Issuer. The information provided in Items 3, 4 and 5 is incorporated by reference in its entirety in this Item 6. On April 9, 2024, Mr. Oliver and the Fund entered into warrant standstill agreements with the Issuer, pursuant to which each agreed not to exercise their outstanding warrants to buy the Issuer's common stock, including the Warrants purchased by the Fund on April 9, 2024. The form of each of those agreements is included as Exhibit "B" and Exhibit "C" to this Amendment, respectively. Each agreement will remain in effect until terminated upon 61 days' written notice to the Issuer from the applicable reporting person. Accordingly, the reporting persons currently do not beneficially own any of the common shares underlying the warrants covered by the agreements, as defined for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.

Material to be Filed as Exhibits

Item 7. Material to be Filed as Exhibits. The reporting persons entered into a Joint Filing Agreement dated September 29, 2023, which was filed as Exhibit "A" to the initial filing of this Schedule 13D. Attached as Exhibit "B" to this Amendment is the Form of Warrant Standstill Agreement between Daniel Oliver Jr. and the Issuer dated April 9, 2024. Attached as Exhibit "C" to this Amendment is the Form of Warrant Standstill Agreement between Myrmikan Gold Fund, LLC and the Issuer dated April 9, 2024. [Signature page follows] SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 12, 2024 /s/ Daniel Oliver Jr Daniel Oliver Jr Myrmikan Gold Fund, LLC By: /s/ Daniel Oliver Jr Manager of Myrmikan Capital, LLC Myrmikan Capital, LLC By: /s/ Daniel Oliver Jr Manager EXHIBIT "B" Form of Warrant Standstill Agreement - Daniel Oliver Jr. Daniel Oliver Jr. 713 Silvermine Road New Canaan, Connecticut 06840 April 9, 2024 Rise Gold Corp. 345 Crown Point Circle, Unit 600 Grass Valley, California 95945 Re: Warrant Standstill Agreement To: Rise Gold Corp. (the " Company ") In connection with the private offering by the Company on this date of units, each of which is comprised of one common share of the Company and one-half of a common share purchase warrant of the Company, this letter confirms the understanding and agreement of the undersigned and the Company regarding the following matters (this " Agreement "): 1. While this Agreement remains in effect, the undersigned will not exercise and the Company will not facilitate the exercise of any of the warrants of the Company held by the undersigned as of this date, including, for greater clarity, the following warrants (collectively, the " Warrants "): Certificate Number Number of Warrants Expiry Date Current Exercise Price 230217-DW02.02 115,000 2-17-25 US$0

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.